BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 17228149)

  • 1. Celecoxib and curcumin additively inhibit the growth of colorectal cancer in a rat model.
    Shpitz B; Giladi N; Sagiv E; Lev-Ari S; Liberman E; Kazanov D; Arber N
    Digestion; 2006; 74(3-4):140-4. PubMed ID: 17228149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Celecoxib and curcumin synergistically inhibit the growth of colorectal cancer cells.
    Lev-Ari S; Strier L; Kazanov D; Madar-Shapiro L; Dvory-Sobol H; Pinchuk I; Marian B; Lichtenberg D; Arber N
    Clin Cancer Res; 2005 Sep; 11(18):6738-44. PubMed ID: 16166455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Curcumin synergistically potentiates the growth-inhibitory and pro-apoptotic effects of celecoxib in osteoarthritis synovial adherent cells.
    Lev-Ari S; Strier L; Kazanov D; Elkayam O; Lichtenberg D; Caspi D; Arber N
    Rheumatology (Oxford); 2006 Feb; 45(2):171-7. PubMed ID: 16249246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Curcumin potentiates the pro-apoptotic effects of sulindac sulfone in colorectal cancer.
    Giladi N; Kazanov D; Shpitz B; Aroch I; Kraus S; Arber N
    Expert Opin Investig Drugs; 2010 Apr; 19 Suppl 1():S117-24. PubMed ID: 20374023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of curcumin and green tea catechins prevents dimethylhydrazine-induced colon carcinogenesis.
    Xu G; Ren G; Xu X; Yuan H; Wang Z; Kang L; Yu W; Tian K
    Food Chem Toxicol; 2010 Jan; 48(1):390-5. PubMed ID: 19861145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of colonic aberrant crypt foci by curcumin in rats is affected by age.
    Kwon Y; Malik M; Magnuson BA
    Nutr Cancer; 2004; 48(1):37-43. PubMed ID: 15203376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The anti-proliferative potency of celecoxib is not a class effect of coxibs.
    Schiffmann S; Maier TJ; Wobst I; Janssen A; Corban-Wilhelm H; Angioni C; Geisslinger G; Grösch S
    Biochem Pharmacol; 2008 Jul; 76(2):179-87. PubMed ID: 18547544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of combined use of curcumin and catechin on cyclooxygenase-2 mRNA expression in dimethylhydrazine-induced rat colon carcinogenesis].
    Xu G; Huang W; Zhang WM; Lai ZS; He MR; Wang YD; Zhang YL
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Jan; 25(1):48-52. PubMed ID: 15683997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-regulation of prostaglandin E2 by curcumin is correlated with inhibition of cell growth and induction of apoptosis in human colon carcinoma cell lines.
    Lev-Ari S; Maimon Y; Strier L; Kazanov D; Arber N
    J Soc Integr Oncol; 2006; 4(1):21-6. PubMed ID: 16737669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of azoxymethane-induced colon cancer by combination of low doses of atorvastatin, aspirin, and celecoxib in F 344 rats.
    Reddy BS; Wang CX; Kong AN; Khor TO; Zheng X; Steele VE; Kopelovich L; Rao CV
    Cancer Res; 2006 Apr; 66(8):4542-6. PubMed ID: 16618783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined inhibitory effects of green tea polyphenols and selective cyclooxygenase-2 inhibitors on the growth of human prostate cancer cells both in vitro and in vivo.
    Adhami VM; Malik A; Zaman N; Sarfaraz S; Siddiqui IA; Syed DN; Afaq F; Pasha FS; Saleem M; Mukhtar H
    Clin Cancer Res; 2007 Mar; 13(5):1611-9. PubMed ID: 17332308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Compositions for treatment of cancer and inflammation.
    Lev-Ari S; Lichtenberg D; Arber N
    Recent Pat Anticancer Drug Discov; 2008 Jan; 3(1):55-62. PubMed ID: 18289124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors influencing effects of specific COX-2 inhibitor NSAIDs on growth and differentiation of mouse osteoblasts on titanium surfaces.
    Arpornmaeklong P; Akarawatcharangura B; Pripatnanont P
    Int J Oral Maxillofac Implants; 2008; 23(6):1071-81. PubMed ID: 19216276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel nitro-oxy derivatives of celecoxib for the regulation of colon cancer cell growth.
    Bozzo F; Bassignana A; Lazzarato L; Boschi D; Gasco A; Bocca C; Miglietta A
    Chem Biol Interact; 2009 Dec; 182(2-3):183-90. PubMed ID: 19682443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of azoxymethane and curcumin on transcriptional levels of cyclooxygenase-1 and -2 during initiation of colon carcinogenesis.
    Kwon Y; Magnuson BA
    Scand J Gastroenterol; 2007 Jan; 42(1):72-80. PubMed ID: 17190766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Curcumin synergistically potentiates the growth inhibitory and pro-apoptotic effects of celecoxib in pancreatic adenocarcinoma cells.
    Lev-Ari S; Zinger H; Kazanov D; Yona D; Ben-Yosef R; Starr A; Figer A; Arber N
    Biomed Pharmacother; 2005 Oct; 59 Suppl 2():S276-80. PubMed ID: 16507392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Celecoxib induces p53-PUMA pathway for apoptosis in human colorectal cancer cells.
    Liu HF; Hsiao PW; Chao JI
    Chem Biol Interact; 2008 Oct; 176(1):48-57. PubMed ID: 18760266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical management of adenomatous polyposis in patients with hereditary non-polyposis colorectal cancer and familial adenomatous polyposis].
    Sheng JQ; Li SR; Yang XY; Zhang YH; Su H; Yu DL; Yan W; Geng HG
    Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(8):526-9. PubMed ID: 16681880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic inhibition effect of tumor growth by using celecoxib in combination with oxaliplatin.
    Zhao S; Cai J; Bian H; Gui L; Zhao F
    Cancer Invest; 2009 Jul; 27(6):636-40. PubMed ID: 19387877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Celecoxib, a cyclooxygenase-2 inhibitor, induces apoptosis in human osteosarcoma cell line MG-63 via down-regulation of PI3K/Akt.
    Liu B; Shi ZL; Feng J; Tao HM
    Cell Biol Int; 2008 May; 32(5):494-501. PubMed ID: 18078766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.